---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-274383"
form_type: "8-K"
ticker: "LXRX"
cik: "0001062822"
company_name: "LEXICON PHARMACEUTICALS, INC."
filed_at: "2025-11-10T23:59:59+00:00"
generated_at: "2026-05-16T22:12:11.544631+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Lexicon corrects prospectus error on EY internal control audit exemption

## Summary
- Prospectus supplement inadvertently stated EY audited internal controls as of Dec 31, 2024.
- As a smaller reporting company/non-accelerated filer, Lexicon is exempt from such audit; EY did not perform it.
- Correction relates to existing $75M at-the-market equity facility with Jefferies LLC.
- No impact on financial statements or current business operations.

## SEC filing metadata
- accession: 0001193125-25-274383
- form_type: 8-K
- ticker: LXRX
- cik: 0001062822
- company_name: LEXICON PHARMACEUTICALS, INC.
- filed_at: 2025-11-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1062822/000119312525274383/0001193125-25-274383-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1062822/000119312525274383/d30705d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-274383
- JSON: https://secwatch.observer/filing/0001193125-25-274383.json
- Plain text: https://secwatch.observer/filing/0001193125-25-274383.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.